Ask AI
evERA Subgroups
evERA: Clinical and Biomarker Subgroup Analysis of Giredestrant + Everolimus in ER+/HER2− ABC Previously Treated with a CDK4/6 Inhibitor

Released: December 22, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 22, 2025